Drugs / MSC (hPPL)
last change Jul 2013 re-read 3 minutes ago

MSC (hPPL)

Cell therapy

Developed for
graft versus host disease
Investigated by
N.M. Wulffraat

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00827398 Jan 2009 → Jul 2013 graft versus host disease N.M. Wulffraat Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MSC (hPPL) ClinicalTrials.gov intervention name — accepted as the source's own label NCT00827398 ↗
Modality Cell therapy “Mesenchymal Stem Cells” NCT00827398 ↗